Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024
Health & Wellness Planning to burn scented candles this Christmas? You may want to reconsider New research has highlighted that they can increase your risk of lung cancer Rowan DunneDecember 11, 2024
Medical and Pharmaceutical University of Cambridge develops ‘zombie’ cell detecting lung cancer urine test It is not the first pee test used to help diagnose the disease, but it is the first of its kind Rowan DunneDecember 6, 2024
Medical and Pharmaceutical AI lung cancer screening tech developer, Imidex, seeks buyer at Chicago conference Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform Rowan DunneDecember 2, 2024
Health & Wellness India gets much needed lung cancer screening program The nation is facing a lung cancer epidemic from the heavy pollution Rowan DunneNovember 29, 2024
Health & Wellness BC woman advocates for lung cancer screening after shocking diagnosis at 39 Even if you have a healthy lifestyle and don't smoke you should still get checked out, she says Rowan DunneNovember 28, 2024
Medical and Pharmaceutical Kentucky governor recognizes Lung Cancer Awareness Month with formal proclamation Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers Rowan DunneNovember 26, 2024
Health & Wellness American Lung Association urges high-risk individuals to get lung cancer screening Only 16.0 per cent of eligible individuals underwent lung cancer screening in 2022 Joseph MortonNovember 20, 2024
Medical and Pharmaceutical GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most The first patient has been screened with the R&D-stage test in a Phase III study Rowan DunneNovember 19, 2024
Medical and Pharmaceutical Korean consortium propels lung cancer drug development with AI, supercomputers It is being led by Seoul's bioscience company J INTS BIO Rowan DunneNovember 18, 2024